Cargando…

Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris

Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly v...

Descripción completa

Detalles Bibliográficos
Autores principales: Giribaldi, Julien, Ragnarsson, Lotten, Pujante, Tom, Enjalbal, Christine, Wilson, David, Daly, Norelle L., Lewis, Richard J., Dutertre, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143535/
https://www.ncbi.nlm.nih.gov/pubmed/32155768
http://dx.doi.org/10.3390/md18030150
_version_ 1783519635185860608
author Giribaldi, Julien
Ragnarsson, Lotten
Pujante, Tom
Enjalbal, Christine
Wilson, David
Daly, Norelle L.
Lewis, Richard J.
Dutertre, Sebastien
author_facet Giribaldi, Julien
Ragnarsson, Lotten
Pujante, Tom
Enjalbal, Christine
Wilson, David
Daly, Norelle L.
Lewis, Richard J.
Dutertre, Sebastien
author_sort Giribaldi, Julien
collection PubMed
description Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly valuable as drug lead compounds. From the venom gland transcriptome of Conus miliaris, we report here on the discovery and characterization of two conopressins, which are nonapeptide ligands of the vasopressin/oxytocin receptor family. These novel sequence variants show unusual features, including a charge inversion at the critical position 8, with an aspartate instead of a highly conserved lysine or arginine residue. Both the amidated and acid C-terminal analogues were synthesized, followed by pharmacological characterization on human and zebrafish receptors and structural investigation by NMR. Whereas conopressin-M1 showed weak and only partial agonist activity at hV1bR (amidated form only) and ZFV1a1R (both amidated and acid form), both conopressin-M2 analogues acted as full agonists at the ZFV2 receptor with low micromolar affinity. Together with the NMR structures of amidated conopressins-M1, -M2 and -G, this study provides novel structure-activity relationship information that may help in the design of more selective ligands.
format Online
Article
Text
id pubmed-7143535
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71435352020-04-14 Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris Giribaldi, Julien Ragnarsson, Lotten Pujante, Tom Enjalbal, Christine Wilson, David Daly, Norelle L. Lewis, Richard J. Dutertre, Sebastien Mar Drugs Article Cone snails produce a fast-acting and often paralyzing venom, largely dominated by disulfide-rich conotoxins targeting ion channels. Although disulfide-poor conopeptides are usually minor components of cone snail venoms, their ability to target key membrane receptors such as GPCRs make them highly valuable as drug lead compounds. From the venom gland transcriptome of Conus miliaris, we report here on the discovery and characterization of two conopressins, which are nonapeptide ligands of the vasopressin/oxytocin receptor family. These novel sequence variants show unusual features, including a charge inversion at the critical position 8, with an aspartate instead of a highly conserved lysine or arginine residue. Both the amidated and acid C-terminal analogues were synthesized, followed by pharmacological characterization on human and zebrafish receptors and structural investigation by NMR. Whereas conopressin-M1 showed weak and only partial agonist activity at hV1bR (amidated form only) and ZFV1a1R (both amidated and acid form), both conopressin-M2 analogues acted as full agonists at the ZFV2 receptor with low micromolar affinity. Together with the NMR structures of amidated conopressins-M1, -M2 and -G, this study provides novel structure-activity relationship information that may help in the design of more selective ligands. MDPI 2020-03-06 /pmc/articles/PMC7143535/ /pubmed/32155768 http://dx.doi.org/10.3390/md18030150 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Giribaldi, Julien
Ragnarsson, Lotten
Pujante, Tom
Enjalbal, Christine
Wilson, David
Daly, Norelle L.
Lewis, Richard J.
Dutertre, Sebastien
Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
title Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
title_full Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
title_fullStr Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
title_full_unstemmed Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
title_short Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
title_sort synthesis, pharmacological and structural characterization of novel conopressins from conus miliaris
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143535/
https://www.ncbi.nlm.nih.gov/pubmed/32155768
http://dx.doi.org/10.3390/md18030150
work_keys_str_mv AT giribaldijulien synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT ragnarssonlotten synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT pujantetom synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT enjalbalchristine synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT wilsondavid synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT dalynorellel synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT lewisrichardj synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris
AT dutertresebastien synthesispharmacologicalandstructuralcharacterizationofnovelconopressinsfromconusmiliaris